Long COVID Virtual Event: Part 2 of 3

Long COVID title slide
Long COVID Virtual Event: Part 2 of 3
February 22, 2023

This is the first meeting in a series of conferences cohosted by the Biotechnology Innovation Organization (BIO) and Solve M.E. that are designed to foster a private-public engagement and create an R&D roadmap for diagnostics and treatments for Long COVID and Post-infection Diseases.

Objective: Convene stakeholders to advance R&D to diagnose and treat Long COVID and post-infection diseases to:

--Increase awareness among drug developers to the unmet need and business opportunity in these indications

--Establish a knowledge base of emerging research in Long COVID and existing body of data in other post-infection diseases (such as dysautonomia, myalgic encephalomyelitis/ chronic fatigue syndrome, mast cell activation, and others).

--Highlight potential biological targets for therapeutic and preventative approaches

--Engage experts and regulators to inform design of clinical studies

--Establish a pre-competitive collaborative network

Recorded on February 21, 2023. Part 2 of 3.

Long COVID Agenda and Speakers List